Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of relapse in breast cancer: changes over time.
Yerushalmi R, Woods R, Kennecke H, Speers C, Knowling M, Gelmon K. Yerushalmi R, et al. Breast Cancer Res Treat. 2010 Apr;120(3):753-9. doi: 10.1007/s10549-009-0510-2. Epub 2009 Aug 22. Breast Cancer Res Treat. 2010. PMID: 19701704
Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials.
Hilton JF, Bouganim N, Dong B, Chapman JW, Arnaout A, O'Malley F, Gelmon KA, Yerushalmi R, Levine MN, Bramwell VH, Whelan TJ, Pritchard KI, Shepherd LE, Clemons M. Hilton JF, et al. Among authors: yerushalmi r. Breast Cancer Res Treat. 2013 Nov;142(1):143-51. doi: 10.1007/s10549-013-2714-8. Epub 2013 Oct 11. Breast Cancer Res Treat. 2013. PMID: 24113743
Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis.
Yerushalmi R, Goldvaser H, Sulkes A, Ben-Aharon I, Hendler D, Neiman V, Ciuraru NB, Bonilla L, Amit L, Zer A, Granot T, Rizel S, Stemmer SM. Yerushalmi R, et al. PLoS One. 2014 Oct 15;9(10):e107273. doi: 10.1371/journal.pone.0107273. eCollection 2014. PLoS One. 2014. PMID: 25330205 Free PMC article.
Malignancy associated SIADH: Characterization and clinical implications.
Goldvaser H, Rozen-Zvi B, Yerushalmi R, Gafter-Gvili A, Lahav M, Shepshelovich D. Goldvaser H, et al. Among authors: yerushalmi r. Acta Oncol. 2016 Sep-Oct;55(9-10):1190-1195. doi: 10.3109/0284186X.2016.1170198. Epub 2016 May 4. Acta Oncol. 2016. PMID: 27142293
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.
Lewin R, Sulkes A, Shochat T, Tsoref D, Rizel S, Liebermann N, Hendler D, Neiman V, Ben-Aharon I, Friedman E, Paluch-Shimon S, Margel D, Kedar I, Yerushalmi R. Lewin R, et al. Among authors: yerushalmi r. Breast Cancer Res Treat. 2016 Jun;157(3):511-6. doi: 10.1007/s10549-016-3836-6. Epub 2016 May 25. Breast Cancer Res Treat. 2016. PMID: 27225387
231 results